Issue of Common Stock Equivalent to Cash. The payments identified in Sections 3.1 and 3.2 as payable in cash or common stock may be paid in cash or newly issued common stock of the Licensee or in common stock of Licensee’s Parent (Entest BioMedical Inc.) at the Licensee’s discretion valued as of the lowest closing price on the principal exchange upon which said common stock trades publicly within the 14 trading days prior to issuance.
Appears in 4 contracts
Samples: License Agreement (Regen BioPharma Inc), License Agreement (Regen BioPharma Inc), License Agreement (Zander Therapeutics, Inc)